PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11755144-5	2001	The caspase inhibitor, Z-Val-Ala-Asp-fluoromethylketone (Z-VAD-fmk), resulted in a dose-dependent inhibition of apoptosis and beta-catenin cleavage.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	23-55	catenin beta 1	Homo sapiens	126-138	
15567157-5	2005	The caspase inhibitor ZVAD blocked beta-catenin cleavage by p-NO-ASA and partially reversed cell growth inhibition by p-NO-ASA but not that by ASA.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	22-26	catenin beta 1	Homo sapiens	35-47	
15067380-6	2004	The cleavage of beta-catenin was inhibited by the caspase inhibitors Z-VAD-fmk and Z-DEVD-fmk.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	69-78	catenin beta 1	Homo sapiens	16-28	
14555707-8	2003	Pretreatment with the caspase inhibitor z-VAD-fmk blocked morphological signs of apoptosis as well as caspase cleavage, and also partially prevented beta-catenin degradation by sulindac metabolites.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	40-49	catenin beta 1	Homo sapiens	149-161	
17030184-6	2006	GTN-induced beta-catenin degradation involves proteases that are sensitive to a broad-spectrum caspase inhibitor, z-VAD-fmk, and to serine protease inhibitors N-tosyl-L-phenylalaline chloromethyl ketone (TPCK) and [4-(2-aminoethyl)-benzenesulfonylfluoride] (AEBSF), whereas the ubiquitin/proteasome pathway is not involved.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	114-123	catenin beta 1	Homo sapiens	12-24	
11755144-5	2001	The caspase inhibitor, Z-Val-Ala-Asp-fluoromethylketone (Z-VAD-fmk), resulted in a dose-dependent inhibition of apoptosis and beta-catenin cleavage.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	57-66	catenin beta 1	Homo sapiens	126-138	
11179455-9	2001	Furthermore, paclitaxel-induced apoptosis and cleavage of beta-catenin and gamma-catenin were inhibited by the pan-caspase inhibitor Z-VAD-FMK and partially inhibited by the caspase-3 inhibitor Z-DEVD-FMK but were not affected by the caspase-1 inhibitor AC-YVAD-CMK.	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone	133-142	catenin beta 1	Homo sapiens	58-70